Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Using annuities and stocks for retirement income explains blending these assets to diversify risk and stabilize cash flow for retirement.
28,656 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Looking for legitimate ways to monetize a few spare minutes? Apps for online surveys that pay let you turn quick poll...
The Washington state Department of Licensing faced a public-relations setback after an AI self-service line used Engl...
A dramatic surge in a single year can turn heads, but investors need more than headlines. This article dives into whe...
When a space tech company makes a big fundraising move, its stock can swing just as fast. Learn why intuitive machine...
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A surprising uptick in the memory sector has traders asking, 'Why is SanDisk stock today?' While SanDisk isn’t traded...
A veteran fund manager challenges Wall Street's reliance on earnings when valuing AI plays, arguing that the E in P/E...
Karman Holdings stock zoomed more than 6% today as the company was added to a major index. Here’s what happened, why ...
Warren Buffett’s moves hint at a bold AI bet. This guide breaks down what makes a killer AI stock and how everyday in...
Three cruise stocks rise and fall on 2025 results and 2026 guidance. This report weighs Royal Caribbean, Carnival, an...
Devon Energy shares surged after an updated 2026 forecast highlighted stronger cash flow and a solid balance sheet. T...